Compare NICE Ltd (NICE) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NICE Ltd vs Regeneron Pharmaceuticals Inc — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 11.9× NICE Ltd's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while NICE Ltd pays none. Which is the better fit depends on your goals.
| NICE | REGN | |
|---|---|---|
Market Cap | $5.91B | $70.47B |
Sector | Technology | Health |
52-Week High | $170.37 | $812.27 |
52-Week Low | $83.15 | $545.46 |
Enterprise Value | $5.69B | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
